Compare BDRX & VBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDRX | VBIO |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 1.8M |
| IPO Year | 2015 | 2021 |
| Metric | BDRX | VBIO |
|---|---|---|
| Price | $2.49 | $0.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 46.7K | ★ 106.8K |
| Earning Date | 09-12-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.60 | $0.46 |
| 52 Week High | $11.88 | $0.61 |
| Indicator | BDRX | VBIO |
|---|---|---|
| Relative Strength Index (RSI) | 37.01 | 42.63 |
| Support Level | $2.22 | $0.47 |
| Resistance Level | $3.68 | $0.61 |
| Average True Range (ATR) | 0.26 | 0.06 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 6.76 | 39.69 |
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.